Vaccine Development Workflows

Accelerate vaccine development

Workflow solutions to accelerate your COVID-19 cell response and vaccine development


Virus related workflow graphic

Vaccine development workflows vary depending upon the platform (e.g. inactivated virus vs. DNA vaccine) chosen, each having its own advantages. CEPI, the Coalition for Epidemic Preparedness Innovations, and many other organizations promote such diverse approaches during a pandemic in order to increase the likelihood of success against the infectious agent.

Here we've simplified the view of a variety of virus-related workflows – from antigen/immunogen and antibody discovery to stable cell line development. Learn more by clicking a workflow below:



Other great resources

Resources related to COVID-19 cellular responses and vaccine development

Here we highlight a few key application notes to support your COVID-19 research. For a complete list of common applications in infectious diseases including cell line development, binding affinity, viral neutralization, viral titer, view our Coronavirus Vaccine Research page.

Systems to accelerate your COVID-19 cellular response and vaccine development

We have validated and compliant laboratory solutions including microplate readers, microplate washers, biopharma and cellular imaging systems to meet your research needs.